European regulator says benefits of AstraZeneca jab outweigh risks

European regulator says benefits of AstraZeneca jab outweigh risks

EU regulator says benefits of vaccine far outweigh risksПодробнее

EU regulator says benefits of vaccine far outweigh risks

EU drugs regulator says benefits of AstraZeneca vaccine outweigh the risksПодробнее

EU drugs regulator says benefits of AstraZeneca vaccine outweigh the risks

'Benefit of Covid-19 vaccine outweighs risk': EU regulatorПодробнее

'Benefit of Covid-19 vaccine outweighs risk': EU regulator

AstraZeneca vaccine benefits outweigh the risks, says Boris JohnsonПодробнее

AstraZeneca vaccine benefits outweigh the risks, says Boris Johnson

EU agency says AstraZeneca clot risk 'very rare'Подробнее

EU agency says AstraZeneca clot risk 'very rare'

EMA: Benefits of AstraZeneca jab outweigh risks | DW NewsПодробнее

EMA: Benefits of AstraZeneca jab outweigh risks | DW News

EU regulator 'firmly convinced' that benefits of AstraZeneca vaccine outweigh the risksПодробнее

EU regulator 'firmly convinced' that benefits of AstraZeneca vaccine outweigh the risks

EU regulator says no indication so far AstraZeneca jab causes clots | AFPПодробнее

EU regulator says no indication so far AstraZeneca jab causes clots | AFP

EU to continue using AstraZeneca jab, says no evidence of bloodclotsПодробнее

EU to continue using AstraZeneca jab, says no evidence of bloodclots

No indication of AstraZeneca vaccine risk, says EU drug regulatorПодробнее

No indication of AstraZeneca vaccine risk, says EU drug regulator

EU body says there's 'no indication' the AstraZeneca’s coronavirus vaccine causes blood clotsПодробнее

EU body says there's 'no indication' the AstraZeneca’s coronavirus vaccine causes blood clots